Guilian Li
Overview
Explore the profile of Guilian Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
428
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu D, Gu Y, Li G, Wang R, Xiao S, Duan H, et al.
BMC Microbiol
. 2025 Jan;
25(1):9.
PMID: 39789455
Mycobacterium tuberculosis (M. tuberculosis) and Mycobacterium abscessus (M. abscessus) are important pathogens that can cause lung diseases. Given the abundance of shared antigens between these two pathogens, evaluating the cross-immunization...
2.
Dong J, Li G, Wang J, Liu B, Xiang Y, Jiang S, et al.
Microb Pathog
. 2024 Nov;
198:107128.
PMID: 39566829
Mycobacterium tuberculosis (Mtb) is the bacterium responsible for causing Tuberculosis (TB) and understanding its mechanisms of virulence, persistence, and pathogenesis is a global research priority. Attenuated strains of Mtb are...
3.
Fang T, Yang S, Liu B, Li W, Sun Q, Liu H, et al.
Front Public Health
. 2024 Sep;
12:1432071.
PMID: 39281085
Objective: Osteoarticular tuberculosis (OATB) is one of the most common forms of extrapulmonary tuberculosis; however, limited epidemiological data are available on this public health concern worldwide, especially in developing countries....
4.
Yu Y, Xiang Y, Liu H, Yang S, Li M, Liu B, et al.
Front Public Health
. 2024 Aug;
12:1405358.
PMID: 39086797
Objectives: This study aimed to investigate the epidemiological and drug resistance (DR) characteristics of extrapulmonary tuberculosis (EPTB) in South-Central China. Methods: EPTB inpatients who were culture-positive for were retrospectively included...
5.
Fang T, Xiang Y, Li W, Liu B, Liu H, Wu Y, et al.
Front Public Health
. 2024 Jul;
12:1432065.
PMID: 39035178
Objectives: To investigate the clinical epidemiological and drug resistance (DR) characteristics of lymph node tuberculosis (LNTB) in Hunan Province which locates in South-central China, and to provide scientific clues for...
6.
Deng L, Wang Q, Liu H, Jiang Y, Xu M, Xiang Y, et al.
Front Microbiol
. 2024 Apr;
15:1290227.
PMID: 38686109
Background: Tuberculosis (TB), mainly caused by (), remains a serious public health problem. Increasing evidence supports that selective evolution is an important force affecting genomic determinants of phenotypes. It is...
7.
Luan X, Fan X, Li G, Li M, Li N, Yan Y, et al.
Int Immunopharmacol
. 2024 Feb;
129:111542.
PMID: 38342063
Research dedicated to diagnostic reagents and vaccine development for tuberculosis (TB) is challenging due to the paucity of immunodominant antigens that can predict disease risk and exhibit protective potential. Therefore,...
8.
Liu B, Su P, Hu P, Yan M, Li W, Yi S, et al.
Infect Drug Resist
. 2024 Feb;
17:403-416.
PMID: 38328339
Background: China is a country with a burden of high rates of both TB and multidrug-resistant TB (MDR-TB). However, published data on pyrazinamide (PZA) resistance are still limited in Hunan...
9.
Yu J, Liu M, Mijiti X, Liu H, Wang Q, Yin C, et al.
Infect Drug Resist
. 2023 May;
16:3157-3169.
PMID: 37235072
Background: The aim of the present study was to investigate the association between vitamin D receptor () gene polymorphism and tuberculosis susceptibility, as well as the potential interaction of host...
10.
Cao B, Mijiti X, Deng L, Wang Q, Yu J, Anwaierjiang A, et al.
Infect Drug Resist
. 2023 May;
16:3117-3135.
PMID: 37228658
Background: Ethionamide (ETH), a structural analogue of isoniazid (INH), is used for treating multidrug-resistant tuberculosis (MDR-TB). Due to the common target InhA, INH and ETH showed cross-resistance in . This...